Business and Project Development Officer
Product Manager, Biotechnologist
PhD, Professor of Biochemistry and Molecular Biology.
30+ years of experience in experimental studies of lipid membranes and membrane proteins. An author of the charge-balance rule of membrane proteins topogenesis. An expert in "lipid mutants", selective lipid labeling, design and assessment of the membrane-targeting compounds.
PhD, Professor of Physics
20+ years of experience in the surface physics, biophysics, quantum chemistry and computational drug design. An expert in simulating interactions of theragnostic nanoparticles with the cell membranes, quantum simulations of the drugs, bridging molecular simulations with bio-medicine and pharmacology.
Chief Executive Officer,
An experienced A.I leader, with previous start up experience in B2B environment, specialist in architecture design and business strategy. Alan assisted the company in securing Series A funding along with leading commercialisation of the technology in addition to a number of pilot roll outs of the software in the USA.
Chief Technical Officer,
PhD in Molecular Biology with 10+ years of experience in drug discovery and scientific software development. Medicinal chemist, expert in development of machine learning models, algorithms for pharmacophore modelling and molecular docking. Author of the number of patented anticancer and antimicrobic biologically active compounds.
Chief Scientific Officer
Dr. Semen Yesylevskyy, PhD, Dr.Sci. in biophisics. 15+ years of experience in molecular modeling, computational drug discovery and scientific software development. Author of unique techniques and algorithms in simulations of curved and asymmetric lipid membranes and assessment of drug-membrane interactions.